Women’s health gets only 6% of private healthcare investment — Davos reframed the gap as an opportunity

What happened

On 20 January 2026, the World Economic Forum launched its inaugural Women’s Health Investment Outlook, developed with Boston Consulting Group and informed by more than 25 organizations across investment, industry and philanthropy.

The headline finding was stark: women’s health receives only 6% of private healthcare investment, despite women representing nearly half of the world’s population. Of that already limited funding, about 90% is concentrated in women’s cancers, reproductive health and maternal health.

Why it mattered

The report shifted the discussion from treating women’s health primarily as a social-policy issue to treating it as an underdeveloped investment market. It highlighted cardiovascular disease, osteoporosis, menopause and Alzheimer’s disease among high-burden areas that remain comparatively undercapitalized.

The economic case was substantial. Forum reporting cited BCG analysis estimating that addressing four major therapeutic areas for women in the United States could unlock a $100 billion-plus market opportunity by 2030.

From funding gap to investable market

The Davos message was that capital does not move at scale on need alone. Investors need stronger evidence, comparable data, clearer reimbursement pathways and better visibility into commercial opportunity. The Outlook therefore paired the funding-gap diagnosis with a call for better market infrastructure.

This makes the development relevant beyond healthcare. It connects Healthcare with Trade & Investment, because the central question is how capital markets can recognize and finance unmet medical demand.

Image credit and rights

Hero image: female doctor, Direct Media via Wikimedia Commons, CC0 1.0 / public-domain dedication. The image is illustrative and does not depict the Davos 2026 launch.

Editorial note

The Davos Collective treats the launch of the Women’s Health Investment Outlook and its 6% investment finding as one canonical Davos 2026 development. Follow-on commentary on the same report is retained as corroborating sourcing rather than counted as separate stories.